Meredith Schultz, MD, MS in

Meredith Schultz, MD, MS

Login to view DISC.
Vice President, Global Medical Expert - Gene Therapies at Ultragenyx
📍 Madison, Wisconsin, United States

Meredith Schultz is the Vice President, Global Medical Expert for Gene Therapies at Ultragenyx. A board-certified pediatric neurologist with over 17 years of experience, she is an expert in treating rare neurogenetic disorders and leading clinical development for novel gene therapies for conditions like Rett syndrome and spinal muscular atrophy, drawing on her advanced genomics education from Johns Hopkins.

She was a Principal Investigator on the pivotal clinical trials for Zolgensma, a revolutionary gene therapy for spinal muscular atrophy.

Read the full overview →
Experience
18 Years
Current Role
Vice President, Global Medical Expert - Gene Therapies
Job Level
Senior
Location
Madison, Wisconsin, United States
Personality Overview

How Meredith shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Meredith cares about

Gene Therapy Trials
Her career is focused on leading clinical development and medical affairs for AAV-based gene therapies at companies like Ultragenyx, Taysha, and Novartis.
Rare Neurologic Disorders
Specializes in treating rare and neurogenetic conditions, describing it as one of her passions, with a specific focus on Rett syndrome and spinal muscular atrophy (SMA).
+5 more topics Login to view topics
Career

Work history

4-2025
Vice President, Global Medical Expert - Gene Therapies
Ultragenyx
2-2024 - 1-2025
Chief Medical Officer
Taysha Gene Therapies
12-2023 - 2-2024
Senior Vice President, Head of Clinical Development and Medical Affairs
Taysha Gene Therapies
7-2021 - 12-2023
Vice President, Sector Lead, Early Stage
Asklepios BioPharmaceutical, Inc. (AskBio)
1-2021 - 7-2021
Executive Medical Director, Head of Gene Therapies Translational Medicine
Novartis Gene Therapies
In the press

Media appearances

Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy. Featured in Bakersfield.com (Associated Press)
See now
Education
2018 - 2020
Individualized Genomics and Health
Johns Hopkins University Advanced Academic Programs
2003 - 2007
Doctor of Medicine - MD
University of Wisconsin-Madison
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Ultragenyx Employees

Explore more public profiles from related professionals.

Howard Horn
Howard Horn
Chief Financial Officer and Executive Vice President, Corporate Strategy
Ultragenyx
LC
Lisa Cimarelli
Associate Director, Culture, Learning & Development
Ultragenyx
 Jessica Houk
Jessica Houk
Director, US Marketing
Ultragenyx
 Glen Zeboski
Glen Zeboski
Senior Director Drug Substance Manufacturing, Downstream and Central Services
Ultragenyx

More profiles

Discover additional public profiles from our index.

Alana Washington, MBA, SHRM-CP
Alana Washington, MBA, SHRM-CP
Regional HR Director
Sidley Austin LLP
 Alan Blyth
Alan Blyth
Head of Infrastructure Services
Tesco Bank
 Alan Cheung
Alan Cheung
Senior Director, Product and Test Engineering
Skyworks Solutions, Inc.
 Wesley Childs
Wesley Childs
Installation technician/ Estimation Manager
Wasatch Window Well Covers
Unlock the full playbookSee exactly how to sell to Meredith. Free, 10 seconds.